Atar, D. Et Al. 2021. New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?. ATHEROSCLEROSIS , vol.319 , 51-61.

Atar, D., Jukema, J. W., Molemans, B., Taub, P. R., Goto, S., Mach, F., ... CerezoOlmos, C.(2021). New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?. ATHEROSCLEROSIS , vol.319, 51-61.

Atar, Dan Et Al. "New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?," ATHEROSCLEROSIS , vol.319, 51-61, 2021

Atar, Dan Et Al. "New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?." ATHEROSCLEROSIS , vol.319, pp.51-61, 2021

Atar, D. Et Al. (2021) . "New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?." ATHEROSCLEROSIS , vol.319, pp.51-61.

@article{article, author={Dan Atar Et Al. }, title={New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?}, journal={ATHEROSCLEROSIS}, year=2021, pages={51-61} }